Y-Intercept (HK)’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,669
Closed -$1.34M – 2090
2026
Q2
$1.34M Sell
2,669
-14,076
-84% -$6.76M 0.03% 910
2026
Q1
$8.23M Buy
+16,745
New +$9.09M 0.16% 154
2025
Q4
– Sell
-711
Closed -$345K – 1989
2025
Q3
$345K Sell
711
-30,854
-98% -$14.4M 0.01% 1344
2025
Q2
$12.8M Buy
31,565
+23,628
+298% +$9.9M 0.31% 40
2025
Q1
$3.95M Buy
7,937
+5,055
+175% +$2.74M 0.27% 80
2024
Q4
$1.5M Buy
2,882
+375
+15% +$206K 0.1% 287
2024
Q3
$1.55M Sell
2,507
-7,587
-75% -$4.49M 0.09% 281
2024
Q2
$5.58M Buy
+10,094
New +$5.78M 0.31% 56
2023
Q3
– Sell
-5,841
Closed -$3.05M – 1596
2023
Q2
$3.05M Buy
5,841
+4,335
+288% +$2.34M 0.32% 49
2023
Q1
$868K Buy
+1,506
New +$849K 0.1% 296
2022
Q4
– Sell
-2,352
Closed -$1.19M – 1345
2022
Q3
$1.19M Buy
+2,352
New +$1.32M 0.12% 264
2021
Q4
– Sell
-433
Closed -$247K – 882
2021
Q3
$247K Sell
433
-1,031
-70% -$566K 0.04% 530
2021
Q2
$739K Sell
1,464
-203
-12% -$95.8K 0.19% 165
2021
Q1
$753K Buy
1,667
+182
+12% +$86.9K 0.2% 155
2020
Q4
$686K Buy
+1,485
New +$696K 0.29% 89

Other funds holding TMO

Y-Intercept (HK)'s TMO Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Thermo Fisher Scientific (TMO) in Q3 2026, closing a stake of 2,669 shares — an estimated $1.34M sold.

Y-Intercept (HK) first reported a position in TMO in Q4 2020 and held it in 15 quarters. The position peaked at $12.8M in Q2 2025. 1,885 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Y-Intercept (HK) reported no remaining Thermo Fisher Scientific position as of Q3 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 2,669 Thermo Fisher Scientific shares in Q3 2026, an estimated $1.34M.
  • Y-Intercept (HK) first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 15 quarters.
  • Y-Intercept (HK)'s Thermo Fisher Scientific position peaked at $12.8M in Q2 2025.
  • 1,885 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.